Zhaoke Ophthalmology Participated in the 21st Chinese International Congress of Ophthalmology and Optometry and Glaucoma Academic Exchange Advisory Meeting

Zhaoke Hong Kong and Nevakar Entered into an Exclusive Licensing Agreement for NVK-002

Zhaoke Ophthalmology Successfully Recruited its First Patient for ZKY001 Phase II Clinical Trial

Zhaoke Hong Kong and PanOptica Entered Into License Agreement for PAN-90806

Conclusion of Series B Fundraising of Approximately US$145 Million for Zhaoke Ophthalmology Marks Big Step Towards Achieving Possible Spin-off and Separate Listing